Recently, the Party Committee of Baiyunshan Hanfang, closely adhering to the guidance of Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, organized its six subordinate Party branches to hold high-quality special organizational life meetings for 2025, focusing on case-based rectification.
Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. has successfully completed its shareholding reform and was officially renamed Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. on March 27, 2026. This rebranding is a significant step in the company’s deepening state-owned enterprise reform and in perfecting its modern corporate governance system, marking a crucial milestone on its path toward market-oriented development and standardized management. Moving forward under its new identity, the company will embark on a new journey of high-quality growth, continuing to focus on the biopharmaceutical and health industries while fulfilling its corporate mission and social responsibilities.